在多中心研究中,ELISpot测试对预测BK多瘤病毒病的风险的有用性
Abiu Sempere1, Natalia Egri2, Angela Gonzalez3
1Department of Infectious Diseases, Vall d'Hebron University Hospital, PROSICS Barcelona, 08035 Barcelona, Spain.
Vaccines
|August 28, 2025
概括
使用ELISpot监测BK多瘤病毒 (BKPyV) 特定的T细胞反应可以预测移植后的再激活风险. 移植后BKPyV免疫的丧失表明脏病的风险较高,而mTOR抑制剂可以提供保护.
科学领域:
- 免疫学
- 移植医学
- 病毒学
背景情况:
- BK多瘤病毒 (BKPyV) 再激活是移植后的常见并发症,可能导致病和移植损失.
- 目前的治疗依赖于早期检测和免疫抑制,增加排斥风险.
- 预测BKPyV重新激活的高风险患者仍然是一个临床挑战.
研究的目的:
- 评估ELISpot测试对BKPyV特异性T细胞反应的有用性.
- 评估T细胞免疫变化对BKPyV病发展的预测价值.
- 确定移植后BKPyV再激活的危险因素和保护策略.
主要方法:
- 涉及72名移植患者的前性多中心研究.
- 在移植前和移植后两个月进行ELISpot测试以评估BKPyV特异性细胞免疫力.
- 统计分析,包括后勤回归,以确定与BKPyV病的关联.
主要成果:
- 九名患者出现了可能的BKPyV病.
- 发现BKPyV特异性T细胞免疫力丧失 (ELISpot阳性或阴性) 和随后的病 (40% 的病例) 之间存在显著的关联.
- 两个月后仍然呈ELISpot阴性患者的风险中等 (14. 5%),而仍然呈阳性患者则没有风险 (0%).
结论:
- 对BKPyV特异性T细胞的ELISpot监测有助于通过重新激活风险对移植受体进行分层.
- 移植后的BKPyV免疫损失与病有关,这表明细胞免疫监测的作用.
- 基于mTOR抑制剂的免疫抑制显示出对BKPyV脏病的保护作用.
更多相关视频
08:04Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
15.9K
06:13Enzyme-linked Immunospot Assay ELISPOT: Quantification of Th-1 Cellular Immune Responses Against Microbial Antigens
Published on: November 23, 2010
35.0K
相关概念视频
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
01:28Kidney Transplant I: Introduction
60
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
60